| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/20/2006 | US7063830 condensation aerosol for delivery of lidocaine, verapamil, diltiazem, isometheptene and lisuride, wherein aerosol is formed by heating a thin layer containing the drug, on a solid support, to produce a vapor of the drug, and condensing the vapor to form aerosol |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | US20060128776 Opioid receptor active compounds |
| 06/15/2006 | US20060128746 Methods, kits and compositions for using pyrrole derivatives |
| 06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/15/2006 | US20060127914 Nicotinic acetylcholine receptor |
| 06/15/2006 | US20060127492 Sustained improver of muscular fatigue |
| 06/14/2006 | EP1669089A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 06/14/2006 | EP1667691A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate |
| 06/14/2006 | EP1667689A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 06/14/2006 | EP1667688A1 2-alkylidene-19-nor-vitamin d derivatives for the treatment of frailty, muscle damage or sarcopenia |
| 06/14/2006 | EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1268418B1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | CN1788019A Neutralizing antibodies against GDF-8 and uses therefor |
| 06/14/2006 | CN1785223A Medicine for treating muscular dystrophy and myasthenia gravis, and its prepn. method |
| 06/13/2006 | US7060836 Lactams as tachykinin antagonists |
| 06/13/2006 | US7060699 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 06/13/2006 | US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries |
| 06/13/2006 | US7060683 for treatment of neurodegeneration, stroke, Alzheimer's, amyotrophy, motor neuron damage, acute central nervous system injury, muscular dystrophy, bone resorption, platelet aggregation, cataracts and inflammation |
| 06/13/2006 | US7060254 Aerosol; heating thin film on solid support; vaporization with air flow |
| 06/08/2006 | US20060122411 Chloride channel opener |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122200 Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies |
| 06/08/2006 | US20060122176 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121135 Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia |
| 06/08/2006 | US20060121007 Generation of neuronal cells for use in the treatment of nervous system disorders; preparing nutrient broth contain nerve growth factor, inoculating with cells, producing neuronal precursor cells or glial precursor cells |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666473A1 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1664269A2 Alpha-keto carbonyl calpain inhibitors |
| 06/07/2006 | EP1663262A2 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/06/2006 | US7057051 Substituted imidazoles as cannabinoid receptor modulators |
| 06/06/2006 | US7057047 reacting 2-diaminopyridine with malic/sulfuric acid to form 2-amino-7-hydroxy-1,8-naphthyridine sulfuric acid salt, reacting in solvent to form phthalimidyl naphthyridine, chlorinating, reducing to hydroxyindolinone, then reacting with 5-methyl-2-oxo-hexyltriphenylphosphonium halide to form racemate |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056712 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/01/2006 | WO2006057375A1 Medicinal preparation for external use |
| 06/01/2006 | WO2004004656A3 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | US20060116349 Methods and compositions for administration of iron for the treatment of restless leg syndrome |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1778820A Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 05/31/2006 | CN1778819A Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053082 Neuroprotectants for treating epilepsy, stroke, Parkinson's disease, multiple sclerosis or amyotropic lateral sclerosis; 5-(3-methyl-4-amino or nitro-phenyl)-1,3-dioxolo[4,5-h][2,3]benzodiazepine; AMPA/cainate antagonistic effect; chemical intermediates |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7052700 Treating gynecological blood stasis, cardio-cerebral vascular diseases, respiratory system and urinary system diseases |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 05/26/2006 | WO2006053923A1 Use of serine-proteinase known as ancrod in the treatment of duchenne muscular dystrophy |
| 05/26/2006 | WO2006053872A1 The use of anti-oxidant compounds for muscle recovery |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | CA2838516A1 Treatment of disease |
| 05/25/2006 | US20060111443 Preventive therapeutic composition for muscular fatigue, pulled muscle and disease attributed thereto |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060110474 Rubrofusarin glycoside-containing composition |
| 05/25/2006 | US20060110368 Medium for culturing autologous human progenitor stem cells and applications thereof |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1474425B1 Deazapurines and uses thereof |
| 05/24/2006 | EP1471944B1 Pharmaceutical composition which improves in vivo gene transfer |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1257181C Androfenic Steroid compounds and method of making and using the same |
| 05/23/2006 | US7049343 Nitrogen compounds such as 3-(N'-(2,6-dinitro-4-trifluoro methylphenyl)-N-(3-methoxyphenylhydrazino)propionic acid, used as glycine transport antagonists for prophylaxis of psychological disorders |
| 05/23/2006 | US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists |
| 05/23/2006 | US7049325 Quinoline derivatives as anti-inflammatory agents |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7048954 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 05/23/2006 | US7048934 Combined regulation of neural cell production |
| 05/23/2006 | US7048909 Aerosols containing nondegraded atenolol, pindolol, esmolol, propranolol, or metoprolol |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006050819A1 Pharmaceutical preparation for the treatment of friedreich’s ataxia |
| 05/18/2006 | WO2005110422A3 Treatment of diseases associated with altered level of amyloid beta peptides |
| 05/18/2006 | US20060106222 Aminoadamantane derivatives as therapeutic agents |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060105966 Novel anticonvulsant derivative salts |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105059 Fruit and/or vegetable derived composition |
| 05/18/2006 | CA2587188A1 Pharmaceutical preparation for the treatment of friedreich's ataxia |